Subjects. The investigators will conduct a randomized, double-blind, placebo-controlled intervention study designed to clinically and mechanistically assess novel therapies targeted at minimizing or preventing diminished nutritive flow to skeletal muscle and impaired capacity for net muscle protein anabolism in elderly. Subjects will be randomized to one of three groups: